Nuance Pharma (shanghai) Co., Ltd
4 clinical trials · Sponsor
◉ Watch Nuance Pharma (shanghai) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT05743075) | Nuance Pharma (shanghai) Co., Ltd | 2023-03-10 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects (NCT05758428) | Nuance Pharma (shanghai) Co., Ltd | 2023-03-06 |
| A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects (NCT05382546) | Nuance Pharma (shanghai) Co., Ltd | 2022-05-23 |
| Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects (NCT04158102) | Nuance Pharma (shanghai) Co., Ltd | 2019-11-07 |
Track Nuance Pharma (shanghai) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.